A carregar...
Interstitial lung disease induced by docetaxel and ramucirumab chemotherapy after nivolumab treatment
Three men (aged 64, 65, and 67 years) with advanced lung cancer who had been treated with nivolumab developed interstitial lung disease (ILD) during chemotherapy with docetaxel and ramucirumab. The treatment was clinically effective; however, the patients experienced immune‐related adverse effects d...
Na minha lista:
| Publicado no: | Respirol Case Rep |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Ltd
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7176744/ https://ncbi.nlm.nih.gov/pubmed/32337046 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rcr2.564 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|